Schebo Mediacarlosribet2015-03-29T15:01:08+02:00 ScheBo media  Focus 2010 lecture on M2-PKThe high sensitivity (c.80%) and high specificity ( 90%) of the M2-PK stool test for colorectal cancer screening and detection, plus benefits for patients, laboratories and doctors, was presented at Focus 2010  Dr. Sanders′ Focus 2009 LectureFocusing on results with faecal pancreatic elastase and faecal lactoferrin from clinical studies conducted at the Royal Hallamshire Hospital in Sheffield, Dr David Sanders discusses the clinical value of faecal diagnostic assays ScheBo® • SARS-CoV-2 Quick™ IgM/IgG 2in1 Combined Rapid Test ScheBo Biotech engineered her own rapid test for the detection of SARS-CoV-2 IgM and IgG antibodies from human whole blood, serum and plasma samples.read more ScheBo® · Calprotectin Smart™ ELISA Test ScheBo Biotech engineered her own ELISA test for the quantitative determination of Calprotectin in stool samples.read more __________________________ ScheBo® · Lactoferrin Smart™ ELISA Test ScheBo Biotech engineered her own ELISA test for the quantitative determination of Lactoferrin in stool samples.read more __________________________ Pancreas Elastase 1 Quick Test study published in Journal of Cystic Fibrosis Polish scientists publish a study of the sensitivity and specificity of the Pancreas Elastase 1 Quick test in comparison to the ELISA test in the \"Journal of Cystic Fibrosis\".read more...__________________________ ScheBo® · Pancreas Elastase 1 Quick™ Canine Test The stool test for the fast and reliable diagnosis/ exclusion of Exocrine Pancreatic Insufficiency in dogs is… now also available as a rapid testread more...__________________________ ScheBo® • Pankreas Elastase 1 Quick™ Test Faecal Pancreatic Elastase 1The Gold Standard for Non-Invasive Exocrine Pancreatic Function Testing… now also available as a rapid testread more...__________________________ 2in1 Colorectal Cancer Screening Test New innovative combined rapid test to simultaneously detect the enzyme biomarker M2-PK and human haemoglobin for improved colorectal cancer screening.read more....__________________________ Meta-analysis published of faecal M2-PK in colorectal cancer screening Authors conclude that \"We recommend faecal M2-PK as a routine test for CRC screening\".read more...__________________________ Biomarker ′M2-PK′ Identified as Key Enzyme in Cancer Diagnosis and Therapy Ground Breaking Findings on Understanding Cancer Published in ′Science′read more...__________________________